A citation-based method for searching scientific literature

Jason L Vassy, Annjanette Stone, John T Callaghan, Margaret Mendes, Laurence J Meyer, Victoria M Pratt, Ronald M Przygodzki, Maren T Scheuner, Jessica Wang-Rodriguez, Steven A Schichman. Genet Med 2019
Times Cited: 13







List of co-cited articles
33 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Adoption of pharmacogenomic testing by US physicians: results of a nationwide survey.
E J Stanek, C L Sanders, K A Johansen Taber, M Khalid, A Patel, R R Verbrugge, B C Agatep, R E Aubert, R S Epstein, F W Frueh. Clin Pharmacol Ther 2012
271
30

Incorporation of pharmacogenomics into routine clinical practice: the Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline development process.
Kelly E Caudle, Teri E Klein, James M Hoffman, Daniel J Muller, Michelle Whirl-Carrillo, Li Gong, Ellen M McDonagh, Katrin Sangkuhl, Caroline F Thorn, Matthias Schwab,[...]. Curr Drug Metab 2014
219
30

Challenges and strategies for implementing genomic services in diverse settings: experiences from the Implementing GeNomics In pracTicE (IGNITE) network.
Nina R Sperber, Janet S Carpenter, Larisa H Cavallari, Laura J Damschroder, Rhonda M Cooper-DeHoff, Joshua C Denny, Geoffrey S Ginsburg, Yue Guan, Carol R Horowitz, Kenneth D Levy,[...]. BMC Med Genomics 2017
57
23

The IGNITE network: a model for genomic medicine implementation and research.
Kristin Wiisanen Weitzel, Madeline Alexander, Barbara A Bernhardt, Neil Calman, David J Carey, Larisa H Cavallari, Julie R Field, Diane Hauser, Heather A Junkins, Phillip A Levin,[...]. BMC Med Genomics 2016
129
23

Considerations for pharmacogenomic testing in a health system.
Roseann S Gammal, Kelly E Caudle, Teri E Klein, Mary V Relling. Genet Med 2019
4
75

Pharmacogenetic Labeling of FDA-Approved Drugs: A Regulatory Retrospective.
Katarzyna Drozda, Michael A Pacanowski, Christian Grimstein, Issam Zineh. JACC Basic Transl Sci 2018
27
23

Addressing phenoconversion: the Achilles' heel of personalized medicine.
Rashmi R Shah, Robert L Smith. Br J Clin Pharmacol 2015
120
23

Estimation of the warfarin dose with clinical and pharmacogenetic data.
T E Klein, R B Altman, N Eriksson, B F Gage, S E Kimmel, M-T M Lee, N A Limdi, D Page, D M Roden, M J Wagner,[...]. N Engl J Med 2009
23

Preemptive pharmacogenetic testing: exploring the knowledge and perspectives of US payers.
Nicholas J Keeling, Meagen M Rosenthal, Donna West-Strum, Amit S Patel, Cyrine E Haidar, James M Hoffman. Genet Med 2019
28
15

The Pharmacogenomics Research Network Translational Pharmacogenetics Program: Outcomes and Metrics of Pharmacogenetic Implementations Across Diverse Healthcare Systems.
J A Luzum, R E Pakyz, A R Elsey, C E Haidar, J F Peterson, M Whirl-Carrillo, S K Handelman, K Palmer, J M Pulley, M Beller,[...]. Clin Pharmacol Ther 2017
81
15

Payer view of personalized medicine.
Edmund J Pezalla. Am J Health Syst Pharm 2016
14
15

Optimizing drug outcomes through pharmacogenetics: a case for preemptive genotyping.
J S Schildcrout, J C Denny, E Bowton, W Gregg, J M Pulley, M A Basford, J D Cowan, H Xu, A H Ramirez, D C Crawford,[...]. Clin Pharmacol Ther 2012
125
15

Pharmacogenomics in the clinic.
Mary V Relling, William E Evans. Nature 2015
371
15

Preemptive clinical pharmacogenetics implementation: current programs in five US medical centers.
Henry M Dunnenberger, Kristine R Crews, James M Hoffman, Kelly E Caudle, Ulrich Broeckel, Scott C Howard, Robert J Hunkler, Teri E Klein, William E Evans, Mary V Relling. Annu Rev Pharmacol Toxicol 2015
262
15

Impact of SLCO1B1 Pharmacogenetic Testing on Patient and Healthcare Outcomes: A Systematic Review.
Jason L Vassy, Sojeong Chun, Sanjay Advani, Sophie A Ludin, Jason G Smith, Elaine C Alligood. Clin Pharmacol Ther 2019
11
18

Pharmacogenomics knowledge for personalized medicine.
M Whirl-Carrillo, E M McDonagh, J M Hebert, L Gong, K Sangkuhl, C F Thorn, R B Altman, T E Klein. Clin Pharmacol Ther 2012
956
15

Clinically actionable genotypes among 10,000 patients with preemptive pharmacogenomic testing.
S L Van Driest, Y Shi, E A Bowton, J S Schildcrout, J F Peterson, J Pulley, J C Denny, D M Roden. Clin Pharmacol Ther 2014
169
15

Preemptive Panel-Based Pharmacogenetic Testing: The Time is Now.
Kristin W Weitzel, Larisa H Cavallari, Lawrence J Lesko. Pharm Res 2017
45
15

Clinical Pharmacogenetics Implementation Consortium Guidelines for HLA-B Genotype and Abacavir Dosing: 2014 update.
M A Martin, J M Hoffman, R R Freimuth, T E Klein, B J Dong, M Pirmohamed, J K Hicks, M R Wilkinson, D W Haas, D L Kroetz. Clin Pharmacol Ther 2014
74
15

Guidance for pharmacogenomic biomarker testing in labels of FDA-approved drugs.
Alexandre Vivot, Isabelle Boutron, Philippe Ravaud, Raphaël Porcher. Genet Med 2015
25
15


Pharmacogenomic biomarker information in drug labels approved by the United States food and drug administration: prevalence of related drug use.
Felix W Frueh, Shashi Amur, Padmaja Mummaneni, Robert S Epstein, Ronald E Aubert, Teresa M DeLuca, Robert R Verbrugge, Gilbert J Burckart, Lawrence J Lesko. Pharmacotherapy 2008
180
15


Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Pharmacogenetics-Guided Warfarin Dosing: 2017 Update.
J A Johnson, K E Caudle, L Gong, M Whirl-Carrillo, C M Stein, S A Scott, M T Lee, B F Gage, S E Kimmel, M A Perera,[...]. Clin Pharmacol Ther 2017
255
15

A pharmacogenetic versus a clinical algorithm for warfarin dosing.
Stephen E Kimmel, Benjamin French, Scott E Kasner, Julie A Johnson, Jeffrey L Anderson, Brian F Gage, Yves D Rosenberg, Charles S Eby, Rosemary A Madigan, Robert B McBane,[...]. N Engl J Med 2013
505
15

A randomized trial of genotype-guided dosing of warfarin.
Munir Pirmohamed, Girvan Burnside, Niclas Eriksson, Andrea L Jorgensen, Cheng Hock Toh, Toby Nicholson, Patrick Kesteven, Christina Christersson, Bengt Wahlström, Christina Stafberg,[...]. N Engl J Med 2013
547
15

Effect of Genotype-Guided Warfarin Dosing on Clinical Events and Anticoagulation Control Among Patients Undergoing Hip or Knee Arthroplasty: The GIFT Randomized Clinical Trial.
Brian F Gage, Anne R Bass, Hannah Lin, Scott C Woller, Scott M Stevens, Noor Al-Hammadi, Juan Li, Tomás Rodríguez, J Philip Miller, Gwendolyn A McMillin,[...]. JAMA 2017
127
15

Warfarin pharmacogenetics.
Julie A Johnson, Larisa H Cavallari. Trends Cardiovasc Med 2015
83
15

Phenocopy and phenoconversion: do they complicate association studies?
Rashmi R Shah, Robert L Smith. Pharmacogenomics 2012
10
20


What will it take to implement genomics in practice? Lessons from the IGNITE Network.
Geoffrey S Ginsburg, Carol R Horowitz, Lori A Orlando. Per Med 2019
10
20


Projected Prevalence of Actionable Pharmacogenetic Variants and Level A Drugs Prescribed Among US Veterans Health Administration Pharmacy Users.
Catherine Chanfreau-Coffinier, Leland E Hull, Julie A Lynch, Scott L DuVall, Scott M Damrauer, Francesca E Cunningham, Benjamin F Voight, Michael E Matheny, David W Oslin, Michael S Icardi,[...]. JAMA Netw Open 2019
36
15


Design of cluster-randomized trials of quality improvement interventions aimed at medical care providers.
Robert J Glynn, M Alan Brookhart, Margaret Stedman, Jerry Avorn, Daniel H Solomon. Med Care 2007
54
7

Evidence and resources to implement pharmacogenetic knowledge for precision medicine.
Kelly E Caudle, Roseann S Gammal, Michelle Whirl-Carrillo, James M Hoffman, Mary V Relling, Teri E Klein. Am J Health Syst Pharm 2016
46
7

MyHealtheVet PHR: a description of users and patient portal use.
Kim M Nazi, Susan S Woods. AMIA Annu Symp Proc 2008
24
7

CSER and eMERGE: current and potential state of the display of genetic information in the electronic health record.
Brian H Shirts, Joseph S Salama, Samuel J Aronson, Wendy K Chung, Stacy W Gray, Lucia A Hindorff, Gail P Jarvik, Sharon E Plon, Elena M Stoffel, Peter Z Tarczy-Hornoch,[...]. J Am Med Inform Assoc 2015
55
7

A report template for molecular genetic tests designed to improve communication between the clinician and laboratory.
Maren T Scheuner, Lee Hilborne, Julie Brown, Ira M Lubin. Genet Test Mol Biomarkers 2012
23
7

"Proving the null hypothesis" in clinical trials.
W C Blackwelder. Control Clin Trials 1982
607
7

Physicians' preparedness for integration of genomic and pharmacogenetic testing into practice within a major healthcare system.
Christina G Selkirk, Scott M Weissman, Andy Anderson, Peter J Hulick. Genet Test Mol Biomarkers 2013
80
7



Effect of the Tool to Reduce Inappropriate Medications on Medication Communication and Deprescribing.
Terri R Fried, Kristina M Niehoff, Richard L Street, Peter A Charpentier, Nallakkandi Rajeevan, Perry L Miller, Mary K Goldstein, John R O'Leary, Brenda T Fenton. J Am Geriatr Soc 2017
30
7

The clinical pharmacogenetics implementation consortium guideline for SLCO1B1 and simvastatin-induced myopathy: 2014 update.
L B Ramsey, S G Johnson, K E Caudle, C E Haidar, D Voora, R A Wilke, W D Maxwell, H L McLeod, R M Krauss, D M Roden,[...]. Clin Pharmacol Ther 2014
226
7


Prevalence of musculoskeletal pain and statin use.
Catherine Buettner, Roger B Davis, Suzanne G Leveille, Murray A Mittleman, Kenneth J Mukamal. J Gen Intern Med 2008
104
7


The SLCO1B1 c.521T>C polymorphism is associated with dose decrease or switching during statin therapy in the Rotterdam Study.
Catherine E de Keyser, Bas J M Peters, Matthijs L Becker, Loes E Visser, André G Uitterlinden, Olaf H Klungel, Céline Verstuyft, Albert Hofman, Anke-Hilse Maitland-van der Zee, Bruno H Stricker. Pharmacogenet Genomics 2014
37
7

Redesign of a computerized clinical reminder for colorectal cancer screening: a human-computer interaction evaluation.
Jason J Saleem, David A Haggstrom, Laura G Militello, Mindy Flanagan, Chris L Kiess, Nicole Arbuckle, Bradley N Doebbeling. BMC Med Inform Decis Mak 2011
13
7


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.